NCT02071004View on ClinicalTrials.gov

DS1040b/Aspirin Drug/Drug Interaction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Acute Ischemic Stroke

Interventions

DRUG

DS-1040b

IV of 6 mg given once over 30 minutes

DRUG

Aspirin

Dispersible tablet, 300mg \& 75 mg, once daily for 5 days

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research Ltd., London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY